Enliven Therapeutics, Inc.
SEC Filing List
ELVN CIK: 0001672619
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Collins Helen Louise | Enliven Therapeutics, Inc. | 05/20/2026 | |
| 144 | Filing for proposed sale of securities u... | JEFFERIES LLC/FA | 05/18/2026 | ||
| SCHEDULE 13G/A | Toppan Merrill/FA | 05/15/2026 | |||
| SCHEDULE 13G/A | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | 05/15/2026 | ||||
| SCHEDULE 13G/A | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 05/15/2026 | |||
| SCHEDULE 13G/A | SCHULTE ROTH & ZABEL LLP /fa | 05/15/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Enliven Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| 8-K | Current report filing | Enliven Therapeutics, Inc. | DONNELLEY FINANCIAL SOLUTIONS /FA/ | 05/07/2026 | |
| No record found. | |||||
| Load More | |||||
